Drug intelligence / Profile preview

aframomum melegueta

Development stage
Unknown
Lead developer
Vidya Herbs
Modality
Small Molecules
Administration
Oral, Topical
01

Overview

Aframomum melegueta is a perennial herb in the ginger family (Zingiberaceae) native to West Africa, widely known as Grains of Paradise. Traditionally used as a spice and in folk and herbal medicine, it is recognized for its pungent seeds containing active compounds such as 6-paradol, 6-gingerol, shogaol, tetrahydroparadol, α-humulene, and β-caryophyllene[1][2][3][7]. Its **mechanisms of action** include anti-inflammatory (COX-2 inhibition, downregulation of inflammatory gene expression), thermogenic (increasing body heat and metabolism), antioxidant, membrane-stabilizing, and neuroactive effects (modulation of endocannabinoid, serotoninergic, and GABAergic systems, inhibition of FAAH)[1][4][6][7]. Traditionally, it has been used for gastrointestinal disorders, stimulating digestion, wound healing, fertility enhancement, pain relief, circulatory improvement, and as an anthelmintic, antiviral, and possibly anticancer and antidiabetic agent[1][2][7]. Human evidence supports its reduction in anxiety and improved sleep quality at moderate doses[4].

Brand names
Grains of Paradise
Other names
Guinea grainsMelegueta pepperAlligator pepper (sometimes used interchangeably but botanically distinct)Aframomum melegueta var. violaceumAframomum meleguetellaAlpinia grana-paradisiAmomum meleguetaCardamomum grana-paradisiCardamomum grandiflorumTorymenes officinalis
02

Targets

XO (Xanthine Oxidoreductase)TRPA1 (Transient receptor potential cation channel subfamily A member 1)PTGS2 (Prostaglandin-Endoperoxide Synthase 2)TRPV1 (Transient receptor potential cation channel subfamily V member 1)

Beyond the preview

Go deeper on aframomum melegueta.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on aframomum melegueta.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call